The present invention relates to compressed tablets for peroral delivery of the cannabinoid cannabidiol (CBD). More particularly, the invention provides a compressed tablet having a tablet weight of 60-1200 mg, said tablet being composed of: 50-95 wt. % of a granulate 5-50 wt. % of lactose and 0-30 wt. % of other tablet excipients wherein the granulate contains: a.2-15 wt. % of cannabidiol b.2-30 wt. % of sucrose fatty acid mono-ester c.30-96 wt. % of lactose and d.0-25 wt. % of other granulate excipients. The compressed tablets according to the invention can conveniently be used in the treatment of psychosis disorders or anxiety disorders. The invention further provides a method for the manufacture of the compressed tablets.
